Emma Barinas-Mitchell

Emma Barinas-Mitchell

Auto-generated profile, based on publicly available information

Emma Barinas-Mitchell

Department of Epidemiology, University of Pittsburgh, Pittsburgh, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
DCDaniel R. Cottam
Daniel R. Cottam
SMSamer G. Mattar
Samer G. Mattar
EBEmma Barinas-Mitchell
Emma Barinas-Mitchell
GEGeorge Eid
George Eid
LKLewis Kuller
Lewis Kuller
PSPhilip R. Schauer
Philip R. Schauer

1 October 2005 in Annals of Surgery
Verified
Journal Article
Closed access
SMSamer G. Mattar
Samer G. Mattar
LVLaura M. Velcu
Laura M. Velcu
MRMordechai Rabinovitz
Mordechai Rabinovitz
ADA J. Demetris
A J. Demetris
AKA M. Krasinskas
A M. Krasinskas
PSPhilip R. Schauer
Philip R. Schauer
To evaluate the effects of surgical weight loss on fatty liver disease in severely obese patients. Nonalcoholic fatty liver disease (NAFLD), a spectrum that extends to liver fibrosis and cirrhosis, is rising at an alarming rate. This increase is occurring in conjunction with the rise of severe obesity and is probably mediated in part by metabolic syndrome (MS). Surgical weight loss operations, probably by reversing MS, have been shown to result in improvement in liver histology. Patients who underwent laparoscopic surgical weight loss operations from March 1999 through August 2004, and who agreed to have an intraoperative liver biopsy followed by at least one postoperative liver biopsy, were included. There were 70 patients who were eligible. All patients underwent laparoscopic operations, the majority being laparoscopic Roux-en-Y gastric bypass. The mean excess body weight loss at time of second biopsy was 59% +/- 22% and the time interval between biopsies was 15 +/- 9 months. There was a reduction in prevalence of metabolic syndrome, from 70% to 14% (P < 0.001), and a marked improvement in liver steatosis (from 88% to 8%), inflammation (from 23% to 2%), and fibrosis (from 31% to 13%; all P < 0.001). Inflammation and fibrosis resolved in 37% and 20% of patients, respectively, corresponding to improvement of 82% (P < 0.001) in grade and 39% (P < 0.001) in stage of liver disease. Surgical weight loss results in significant improvement of liver morphology in severely obese patients. These beneficial changes may be associated with a significant reduction in the prevalence of the metabolic syndrome.

1 May 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
THTimothy M. Hughes
Timothy M. Hughes
LKLewis H. Kuller
Lewis H. Kuller
EBEmma J. M. Barinas-Mitchell
Emma J. M. Barinas-Mitchell
EMEric M. McDade
Eric M. McDade
WKWilliam E. Klunk
William E. Klunk
OLOscar L. Lopez
Oscar L. Lopez
Hypertension is linked to cognitive impairment and the pathologic features of Alzheimer disease (AD), including neurofibrillary tangles and β-amyloid (Aβ) plaques,1 as well as cerebrovascular disease and white matter hyperintensities (WMHs) in the brain.2 Arterial stiffness appears to play a major role in the relationship between hypertension and its consequences in the brain. Mounting evidence implicates arterial stiffness in the pathogenesis of brain aging,3 cerebrovascular disease,3 impaired cognitive function, and dementia in the elderly.4

5 November 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
THTimothy M. Hughes
Timothy M. Hughes
LKLewis H. Kuller
Lewis H. Kuller
EBEmma J.M. Barinas-Mitchell
Emma J.M. Barinas-Mitchell
RMRachel H. Mackey
Rachel H. Mackey
EMEric M. McDade
Eric M. McDade
OLOscar L. Lopez
Oscar L. Lopez
Objective: To determine arterial stiffness and β-amyloid (Aβ) deposition in the brain of dementia-free older adults. Methods: We studied a cohort of 91 dementia-free participants aged 83–96 years. In 2009, participants completed brain MRI and PET imaging using Pittsburgh compound B (PiB; a marker of amyloid plaques in human brain). In 2011, we measured resting blood pressure (BP), mean arterial pressure (MAP), and arterial stiffness by pulse wave velocity (PWV) in the central, peripheral, and mixed (e.g., brachial ankle PWV [baPWV]) vascular beds, using a noninvasive and automated waveform analyzer. Results: A total of 44/91 subjects were Aβ-positive on PET scan. Aβ deposition was associated with mixed PWV, systolic BP, and MAP. One SD increase in baPWV resulted in a 2-fold increase in the odds of being Aβ-positive (p = 0.007). High white matter hyperintensity (WMH) burden was associated with increased central PWV, systolic BP, and MAP. Compared to Aβ-negative individuals with low WMH burden, each SD increase in PWV was associated with a 2-fold to 4-fold increase in the odds of being Aβ-positive and having high WMH. Conclusions: Arterial stiffness was associated with Aβ plaque deposition in the brain, independent of BP and APOE ε4 allele. The associations differed by type of brain abnormality and vascular bed measured (e.g., WMH with central stiffness and Aβ deposition and mixed stiffness). Arterial stiffness was highest in individuals with both high Aβ deposition and WMH, which has been suggested to be a “double hit” contributing to the development of symptomatic dementia.

1 November 2008 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ILIngrid M. Libman
Ingrid M. Libman
EBE. Barinas-Mitchell
E. Barinas-Mitchell
ABA. Bartucci
A. Bartucci
RRR. Robertson
R. Robertson
SAS. Arslanian
S. Arslanian
Objective: We examined the reproducibility of the oral glucose tolerance test (OGTT) in overweight children and evaluated distinguishing characteristics between those with concordant vs. discordant results. Design: Sixty overweight youth (8–17 yr old) completed two OGTTs (interval between tests 1–25 d). Insulin sensitivity was assessed by the surrogate measures of fasting glucose to insulin ratio, whole-body insulin sensitivity index, and homeostasis model assessment of insulin resistance, and insulin secretion by the insulinogenic index with calculation of the glucose disposition index (GDI). Results: Of the 10 subjects with impaired glucose tolerance (IGT) during the first OGTT only three (30%) had IGT during the second OGTT. The percent positive agreement between the first and second OGTT was low for both impaired fasting glucose and IGT (22.2 and 27.3%, respectively). Fasting blood glucose had higher reproducibility, compared with the 2-h glucose. Youth with discordant OGTTs, compared with those with concordant results, were more insulin resistant (glucose/insulin 2.7 ± 1.4 vs. 4.1 ± 1.8, P = 0.006, whole-body insulin sensitivity index of 1.3 ± 0.6 vs. 2.2 ± 1.1, P = 0.003, and homeostasis model assessment of insulin resistance 10.6± 8.1 vs. 5.7 ± 2.8, P = 0.001), had a lower GDI (0.45 ± 0.58 vs. 1.02 ± 1.0, P = 0.03), and had higher low-density lipoprotein cholesterol (117.7 ± 36.6 vs. 89.9 ± 20.1, P = 0.0005) without differences in physical characteristics. Conclusions: Our results show poor reproducibility of the OGTT in obese youth, in particular for the 2-h plasma glucose. Obese youth who have discordant OGTT results are more insulin resistant with higher risk of developing type 2 diabetes mellitus, as evidenced by a lower GDI. The implications of this remain to be determined in clinical and research settings.

1 April 2011 in Menopause
Verified
Journal Article
Closed access
GWGenevieve A. Woodard
Genevieve A. Woodard
MBMaria Mori Mori Brooks
Maria Mori Mori Brooks
EBEmma Barinas-Mitchell
Emma Barinas-Mitchell
RMRachel H. Mackey
Rachel H. Mackey
KMKaren A. Matthews
Karen A. Matthews
KSKim DrPH Sutton-Tyrrell
Kim DrPH Sutton-Tyrrell
Objective: The risk of cardiovascular disease increases after menopause. Recent evidence suggests that it is possible for high-density lipoprotein (HDL) to become proatherogenic or dysfunctional in certain situations. Our objective was to evaluate whether the relationship of HDL cholesterol (HDL-C) to subclinical cardiovascular disease differed across the menopausal transition, which would provide insight for this increased risk. Methods: Aortic calcification (AC), coronary artery calcification (CAC), carotid plaque, and intima media thickness (IMT) were measured in an ancillary study of the Study of Women's Health Across the Nation. Women not using hormone therapy were stratified into premenopausal or early perimenopausal (Pre/EP, n = 316) and late perimenopausal or postmenopausal (LP/Post, n = 224). Results: The inverse relationship of HDL-C to subclinical atherosclerosis measures among Pre/EP women was weaker or reversed among LP/Post women, adjusted for age, site, race, systolic blood pressure, glucose, body mass index, smoking, menopause status, and low-density lipoprotein cholesterol. Specifically, multivariable modeling demonstrated an inverse association between HDL-C level and AC and IMT among Pre/EP women; however, the protective effect of HDL-C for AC, left main CAC, carotid plaque, and IMT was not seen in LP/Post women. In a small subset (n = 53), LP/Post women had more total and small HDL particles, higher triglyceride levels, and more total low-density lipoprotein particles compared with Pre/EP women (P < 0.05). Conclusions: These results suggest that the protective effect of HDL may be diminished as women transition in menopause. Future studies should examine whether this may be due to changes in HDL size, functionality, or related changes in other lipids or lipoproteins.